For verification of specificity of dDT2219 (DT2219 and BIC as controls), we performed a proliferation assay with HPB-MLT cells (T-cell leukemia cell line expressing CD3 but not CD19 or CD22). This evidence concerns the gene CD22 and T-cell leukemia.